326.84MMarket Cap
LossP/E TTM
Akebia Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-07-24The current valuation score of Akebia Therapeutics Inc is 9.03, ranking 60 out of 155 in the Pharmaceuticals industry. Its current P/E ratio is -15.13, which is -92.78% below the recent high of -1.09 and -380.25% above the recent low of -72.67.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.